RxDoctor Payments Data

Michelle Cilento

Physician Assistant · Rochester, NYNPI 1548299316

Payments from drug & device makers

$5,580in general payments, 2019–2025

Across 248 payments — averaging $22.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$904
  • Sumitomo Pharma America, Inc.$792
  • Johnson & Johnson$788
  • Pfizer$457
  • Urovant Sciences Inc$215
  • Teleflex LLC$197
  • plus $2K from 28 others

What the payments were for

  • Food & beverage$5,30795%
  • Education$2735%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,580 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
XtandiEnzalutamide15$208,535
GemtesaVibegron195$166,817
MyrbetriqMirabegron211$149,246
Mirabegron ErMirabegron57$26,402
Testosterone40$12,828
Tamsulosin Hcl764$12,118
BotoxOnabotulinumtoxina15$11,603
Trospium Chloride147$10,097
XyostedTestosterone Enanthate12$9,644
Finasteride383$5,365
Testosterone Cypionate91$5,125
Methenamine Hippurate50$4,954
Silodosin30$2,971
Solifenacin Succinate89$2,847
Oxybutynin Chloride ErOxybutynin Chloride129$2,749

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncXtandi, Myrbetriq$904$357,782226 claims
Sumitomo Pharma America, Inc.Gemtesa$792$166,817195 claims
AbbVieBotox$147$11,60315 claims
Antares Pharma, Inc.Xyosted$195$9,64412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Rochester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →